Budesonide (micronized) 90mcg/inh, 180mcg/inh; dry pwd for inhalation. Pulmicort Flexhaler is available as a dry powder for inhalation containing budesonide in the following 2 strengths: 90 mcg and ...

AstraZeneca will discontinue the production of PULMICORT® (budesonide) 100 and 200 µg/dose HFA pMDI (pressurised metered dose inhaler) due to complex manufacturing issues related to technical aspects ...

Pulmicort (budesonide) can cause common side effects such as nasal issues, sore throat, runny nose, and nausea. Specific side effects vary between the Flexhaler and Respules forms. Serious side ...

AstraZeneca announced this week that it will discontinue the production of Pulmicort (budesonide) 100 and 200 µg/dose HFA (hydrofluoroalkane) pressurized metered-dose inhaler (pMDI) due to ...

Budesonide (Pulmicort (400 mcg)) is a corticosteroid, prescribed for inflammatory bowel disease, asthma, and also for breathing trouble. Budesonide is indicated for: 1. Treatment of Mild to Moderate ...

What is budesonide for nebulization used for? Budesonide for nebulization is commonly used as a controller medicine for asthma, a long-term lung disease involving narrow and inflamed airways, which ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bj53j9/pulmicort) has announced the addition of the "Pulmicort (Asthma ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Budesonide (Pulmicort (0.25 mg)) is a ...

It's another setback for AstraZeneca ($AZN). A U.S. court ruled against the drugmaker in a long-running patent fight over its asthma drug Pulmicort Respules. That ...

A US court has confirmed that a key patent on AstraZeneca’s Pulmicort Repsules is invalid and Actavis has immediately launched its version of the asthma drug. A US court has confirmed that a key ...